García JR, Moreno SF, Halabe CJ, Hamui SA

Language: Spanish
References: 15
Page: 84-89
PDF size: 65.79 Kb.

ABSTRACT

Background: Vaccination is one of the key achievements of preventive medicine increasing adult life expectancy by more than 30% in the last 50 years. Quality of life and longevity improved as vaccination has afforded protection against some biological agents that cause disease. Objective: To investigate the vaccination scheme in adults that attend the ABC Medical Center categorizing them by pathological and non-pathological medical history. Methods: A cross-sectional descriptive study was undertaken applying a questionnaire to patients and their relatives over the age of 19, who attended the ABC Medical Center in both campus: Santa Fe and Observatorio. Results: The population that attended the hospital was lacking in adequate vaccination coverage taking into account those vaccines required for age, life-style and risk factors. Conclusions: It is necessary to create a preventive culture among both health professionals and the general population in order to achieve a complete vaccination coverage.

REFERENCES

1. Halabe CJ, Hamui SA, Lifshitz GA, Nellen HH, Tapia CR. Vacunación en el Adulto. Tercera Edición. México: McGraw-Hill Interamericana; 2008.

2. 2 .Hamui SA, Irigoyen CA, Fernández OM. Los retos de la vacunación en los adultos. México: Órgano informativo del Departamento de Medicina Familiar; 2005.

3. Hillson CM, Barash JH, Buchanan EM. Adult vaccination. Prim Care. 2011; 38 (4): 611-32.

4. Hamui SA, Fernández OM, Nellen HH, Halabe CJ. Vacunación en el adulto: influencia de factores sociales. Memorias del Primer Congreso Latinoamericano de Medicina familiar. México: Editorial Medicina Familiar Mexicana; 2008.

5. Trejo VB, Mendoza ALR, Palma CO, Hernández AM, Téllez RS. Encuesta Nacional de Cobertura de Vacunación (influenza, neumococo y tétanos) en adultos mayores de 60 años en México. Salud Publica Mex. 2012; 54: 39-46.

6. Singleton JA, Greby SM, Wooten KG, Walker FJ, Strikas R. Influenza, Pneumococcal, and tetanus toxoid vaccination of adults. United States, 1993-1997. MMWR Morb Mortal Wkly Rep. 2000; 49: 39-62.

7. Chapel C. Recommennded adult immunization shedule: United States, 2013. Ann Intern Med. 2013; 158: 191-9.

8. Halabe CJ, Hamui SA, Guerra FR, Martínez CM. Vacunación en el adulto mayor. México: Editorial Alfil; 2011.

9. Bridges CB, Woods L, Coyne-Beasley C. Recommended adult immunization schedule: United States, 2013. Ann Intern Med. 2013; 158: 191-199.

10. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007; 357: 1373-1381.

11. Van Kerkhove MD, Vandemaele KAH, Shinde V, Jaramillo-Gutierrez G, Koukounari A et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 2011; 8 (7): e1001053.

12. Karen R, Broder MD, Margaret M, Cortese MD, Johnk K, Iskander MD et al. Preventing tetanus, diphtheria and among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). US Department of Health and Human Services, Centers for Disease Control and Prevention, 2006.

13. Insigna RP, Glass AG, Rush BB. diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Ob- stet gynecol. 2004; 191 (1): 105-13.

14. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007; 356: 1915-27.

15. Oxman MN, Levin MJ, Johnson G, Schmader KE, Straus SE, Gelb LD. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005; 352: 2271-84.